Morpholine → 6,6-Dimethyl-8-(1-oxetan-3-yl-piperidin-4-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
Reaction equation
[NH:1]1[CH2:6][CH2:5]O[CH2:3][CH2:2]1.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].[CH:21]([C:23]1[CH:24]=[CH:25][C:26]2[C:38](=[O:39])[C:37]3[C:36]4[C:31](=[CH:32][C:33]([C:40]#[N:41])=[CH:34][CH:35]=4)[NH:30][C:29]=3[C:28]([CH3:43])([CH3:42])[C:27]=2[CH:44]=1)=O.[O:45]1[CH2:48][C:47](=O)[CH2:46]1>C1COCC1>[CH3:42][C:28]1([CH3:43])[C:29]2[NH:30][C:31]3[C:36](=[CH:35][CH:34]=[C:33]([C:40]#[N:41])[CH:32]=3)[C:37]=2[C:38](=[O:39])[C:26]2[CH:25]=[CH:24][C:23]([CH:21]3[CH2:3][CH2:2][N:1]([CH:47]4[CH2:46][O:45][CH2:48]4)[CH2:6][CH2:5]3)=[CH:44][C:27]1=2Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
With the same condition as the method for synthesizing the Compound B3-32 (morpholine (6 μl, 1.5 eq.) and sodium triacetoxy borohydride (81 mg, 2.0 eq.) were added to THF (1 ml) solution of the Compound B2-29: 8-formyl-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile (30 mg, 0.095 mmol), and stirred at room temperature for 1 hour. The reaction solution was filtered to remove insoluble matters. The residues obtained after concentration under reduced pressure were purified by high performance liquid chromatography to obtain the Compound B3-32 (6,6-dimethyl-8-morpholin-4-yl methyl-11-oxo-6,11-dihydro-5H-benzo carbazole-3-carbonitrile) (19 mg, 50%)), the title compound was synthesized from the Compound B3-13-2 and oxetan-3-one.
Workup
- customWith the same condition as the method for synthesizing the Compound
- filtrationThe reaction solution was filtered
- customto remove insoluble matters
- customThe residues obtained
- concentrationafter concentration under reduced pressure
- customwere purified by high performance liquid chromatography
- customto obtain the Compound
Sources & evidence
- ORD record
- ord-1952870e6d774c6aa6359839fe36fe86
- Source dataset
- uspto-grants-2016_06
- Patent number
- US09365514B2
Reaction notes
Loading…